eISSN: 2450-4459
ISSN: 2450-3517
Lekarz POZ
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
4/2018
vol. 4
 
Share:
Share:
more
 
 
abstract:
Review paper

Fatty liver disease and diabetes

Monika Pazgan-Simon

Online publish date: 2018/10/15
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Nonalcoholic steatohepatitis is one of the most common hepatologic diagnoses. About 30% adults

have NAFLD in developed countries. Diabetes and metabolic syndrome often coexist with NAFLD. Among patients we observe a natural history of this disease: hepatosteatosis (NAFL), steatohepatitis (NASH) with and without fibrosis, liver cirrhosis,

and hepatocellular carcinoma. Diagnostics tools are USG of the liver, biochemical tests: triglyceride level, ALT, and AST. There are dietic treatments and some physical exercise, with final weight loss, then some drugs like metformin, statins, or bariatric surgery.
keywords:

liver steatosis, nonalcoholic steatohepatitis, diabetes

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.